KINGSOFT (03888) purchased 356,600 shares for 9.9999 million Hong Kong dollars on December 5th.
Kingsoft Corporation (03888) announced that on December 5, 2025, the company will spend 9.9999 million Hong Kong dollars to repurchase 356,600 shares, at a repurchase price of 27.92-28.46 Hong Kong dollars per share.
KINGSOFT (03888) announced that on December 5, 2025, the company will repurchase 356,600 shares at a total cost of HK$9.999 million, with a repurchase price per share ranging from HK$27.92 to HK$28.46.
Related Articles
HAOHAI BIOTEC (06826) spent 837,000 Hong Kong dollars to repurchase 30,500 shares on December 5th.
The controlling shareholder of KONTA CHINA (01312) remains unchanged. Shanxi Construction Investment holds 52.44% of the shares and Shanxi Communications holds 90% of the shares have been transferred to the Shanxi Provincial State-owned Assets Supervision and Administration Commission.
CSPC PHARMA (01093): GLP-1/GIP receptor biased agonist dual peptide injection approved for clinical trials in the United States.
HAOHAI BIOTEC (06826) spent 837,000 Hong Kong dollars to repurchase 30,500 shares on December 5th.
The controlling shareholder of KONTA CHINA (01312) remains unchanged. Shanxi Construction Investment holds 52.44% of the shares and Shanxi Communications holds 90% of the shares have been transferred to the Shanxi Provincial State-owned Assets Supervision and Administration Commission.
CSPC PHARMA (01093): GLP-1/GIP receptor biased agonist dual peptide injection approved for clinical trials in the United States.
